
    
      Patients with advanced FIGO stage IIIB - IV high grade serous or endometrioid ovarian,
      fallopian tube, or peritoneal cancer treated with standard first-line treatment, combining
      platinum-taxane chemotherapy and bevacizumab concurrent with chemotherapy and in maintenance.
    
  